Galbán N.
56
Coauthors
5
Documentos
Volumen de publicaciones por año
Cargando gráfico
| Año de publicación | Num. Publicaciones |
|---|---|
| 2020 | 2 |
| 2022 | 3 |
Publicaciones por áreas de conocimiento
Cargando gráfico
| Área de conocimiento | Num. Publicaciones |
|---|---|
| Bioquímica | 3 |
| Cáncer | 2 |
| Salud Pública | 1 |
| Psicopatología | 1 |
| Dolor | 1 |
| Enfermedad cardiovascular | 1 |
| Lípido | 1 |
Publicaciones por áreas temáticas
Cargando gráfico
| Área temática | Num. Publicaciones |
|---|---|
| Enfermedades | 4 |
| Farmacología y terapéutica | 3 |
| Fisiología humana | 2 |
| Salud y seguridad personal | 1 |
| Problemas sociales y servicios a grupos | 1 |
| Fisiología y materias afines | 1 |
| Medicina y salud | 1 |
Principales fuentes de datos
| Origen | Num. Publicaciones |
|---|---|
| Scopus | 5 |
| Google Scholar | 0 |
| RRAAE | 0 |
Cargando gráfico
Coautores destacados por número de publicaciones
| Coautor | Num. Publicaciones |
|---|---|
| Valmore Bermúdez | 5 |
| González M.C. | 4 |
| Nava M. | 3 |
| Rojas M. | 3 |
| Salazar-Vílchez J. | 3 |
| Torres W. | 2 |
| de Sanctis J.B. | 2 |
| Ortega A. | 2 |
| Añez-Ramos R. | 2 |
| Morillo V. | 1 |
Cargando gráfico
Top Keywords
Cargando gráfico
Publicaciones del autor
Metabolic Reprogramming in Cancer Cells: Emerging Molecular Mechanisms and Novel Therapeutic Approaches
ReviewAbstract: The constant changes in cancer cell bioenergetics are widely known as metabolic repro-gramming. ReprPalabras claves:Carbohydrates, Energy metabolism, immunotherapy, inflammation, Metabolic reprogramming, neoplasms, tumor microenvironmentAutores:de Sanctis J.B., Galbán N., Garrido B., González M.C., Navarro C., Ortega A., Santeliz R., Valmore Bermúdez, Vera I.Fuentes:scopusPsycho-Neuro-Endocrine-Immunological Basis of the Placebo Effect: Potential Applications beyond Pain Therapy
ReviewAbstract: The placebo effect can be defined as the improvement of symptoms in a patient after the administratiPalabras claves:Analgesia, Cannabinoids, Conditioning, Depression, hormones, Opioid, Pain, Parkinson’s Disease, placebo effect, PsychoneuroimmunologyAutores:Ariza D., Chávez-Castillo M., Díaz-Camargo E.A., Galbán N., Medina-Ortiz O., Nava M., Ortega A., Riaño-Garzón M.E., Rojas M., Salazar-Vílchez J., Valmore BermúdezFuentes:scopusAnti-aging effect of metformin: A molecular and therapeutical perspective
ReviewAbstract: Aging is a time-dependent inevitable process, in which cellular homeostasis is affected, which has aPalabras claves:ageing, Anti-ageing drugs, Geronto-protective properties, Metformin, Type 2 Diabetes mellitusAutores:Cano-Ponce C., D’marco L., Galbán N., Gomez Y., González M.C., Herazo Y., Morillo V., Nava M., Rojas M., Rojas-Quintero J., Torres W., Valmore Bermúdez, Velasco M.Fuentes:scopusPrevalence of physical inactivity and associated cardiometabolic risk factors: A cross-sectional study
ArticleAbstract: Background: Physical inactivity represents a public health problem associated with non-communicablePalabras claves:Leisure time, Physical inactivity, risk factor, sedentary, transportationAutores:Añez-Ramos R., Galbán N., Gallo V., González M.C., Lameda V., Luzardo E., Olivar L.C., Ponce C.C., Ramírez P., Rojas M., Salazar-Vílchez J., Torres W., Valmore BermúdezFuentes:scopusSpecialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis
ReviewAbstract: Cardiovascular disease (CVD) is a global public health issue due to its high morbidity, mortality, aPalabras claves:atherosclerosis, inflammation, Intimal hyperplasia, Reperfusion injury, resolution, Specialized proresolving mediatorsAutores:Añez-Ramos R., Castro A., Dávila L.C.A., de Sanctis J.B., Diaz A., Durán-Agüero S., Galbán N., González M.C., Nava M., Parra H., Pírela D., Rojas-Gómez D.M., Salazar-Vílchez J., Valmore Bermúdez, Villasmil N.Fuentes:scopus